国家自然科学奖汇报资料
This presentation is the property of its rightful owner.
Sponsored Links
1 / 11

肿瘤免疫逃逸和生物调变分子机制的研究 PowerPoint PPT Presentation


  • 104 Views
  • Uploaded on
  • Presentation posted in: General

国家自然科学奖汇报资料. 肿瘤免疫逃逸和生物调变分子机制的研究. 郭亚军(第二军医大学). 肿瘤杀伤. 肿瘤发生发展转移. 肿瘤识别. 免疫调节. 肿瘤排斥. 研究背景. 肿瘤抗原 —— 性质与提呈 机体反应 —— 识别与排斥 免疫逃逸与转移 —— 粘附受体 免疫调节 —— 共刺激分子. 发现点之一. 肿瘤细胞存在肿瘤特异性 抗原 肿瘤特异性抗原的隐蔽是 由于其提呈功能的系统性缺失 肿瘤抗原提呈系统修复和重建的新理论. 细胞融合肿瘤抗原提呈模型. APC. 共刺激分子. MHC. 细胞融合. +. Tumor Vaccine.

Download Presentation

肿瘤免疫逃逸和生物调变分子机制的研究

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


5884033

国家自然科学奖汇报资料

肿瘤免疫逃逸和生物调变分子机制的研究

郭亚军(第二军医大学)


5884033

肿瘤杀伤

肿瘤发生发展转移

肿瘤识别

免疫调节

肿瘤排斥


5884033

研究背景

  • 肿瘤抗原——性质与提呈

  • 机体反应——识别与排斥

  • 免疫逃逸与转移——粘附受体

  • 免疫调节——共刺激分子


5884033

发现点之一

  • 肿瘤细胞存在肿瘤特异性抗原

  • 肿瘤特异性抗原的隐蔽是由于其提呈功能的系统性缺失

  • 肿瘤抗原提呈系统修复和重建的新理论


5884033

细胞融合肿瘤抗原提呈模型

APC

共刺激分子

MHC

细胞融合

+

Tumor Vaccine

Tumor cell

cytokines


5884033

MHC class I

molecule

Tumor antigen

CD8+

T cell

T-cell receptor

Cytotoxic

T cell

APC

Co-stimulatory

molecule

Fusion

Tumor

cell

Receptor for

co-stimulatory

molecule

CD8+

T cell

CD4+

T cell

MHC class II

molecule

cytokines


5884033

2000年《Nature Med》综述对本文的引用


5884033

tumor

T cell

tumor

T cell

MHC-I

TCR

MHC-I

TCR

CD8

CD8

MHC-II

MHC-II

TCR

TCR

CD4

CD4

41BBL

41BB

41BBL

41BB

B7

CD28

B7

CD28

ICAM-1

LFA-1

ICAM-1

LFA-1

bs-mAb

Bridge tumor cell to T cells by bi-specific mAb greatly facilitate the interaction of adhesion molecular that costimulate T cell activation


5884033

MHC-I

The First Step

Treatment of tumor cell in vitro with combination of cytokines to enhance tumor antigen proccessing and expression of adhesion molecule

B7

MHC-II

Tumor Cells

ICAM-1

Tumor Cells

Cytokines Treating


5884033

Tumor Cells

Tumor Cells

+

The Second Step

Bi-specific mAb coating on the cytokine treated tumor cell surface


5884033

Nature Medicine, 3(4) :451- 455

PNAS, 101(14): 4990- 4995

Cancer Gene Therapy, 12: 769- 777


  • Login